Rishi Gupta - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Rishi Gupta - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Rishi Gupta for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.66M $170M $22.14 May 16, 2024 Indirect
Stock Option (right to buy) 23.4K Feb 13, 2024 Direct Common Stock

Transactions reported by Rishi Gupta for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.